Introduction/Overview
Magnolorine chloride (CAS number: 6681-18-1) is a naturally occurring aporphine alkaloid widely distributed in the Magnoliaceae family and other plants. As a natural product with multiple biological activities, (+) - Magnoline (also known as α - Magnoline) has received widespread attention in the fields of pharmacology and natural product chemistry in recent years due to its significant pharmacological effects such as anti-inflammatory, immune regulation, neuroprotection, and anti-tumor effects. Its unique molecular structure endows it with the ability to regulate multiple targets and pathways, making it a promising candidate for applications in cardiovascular protection, neurodegenerative diseases, tumor therapy, and anti infection.
This article provides a systematic review of the chemical structure and physicochemical properties, plant sources, and extraction methods of magnolol hydrochloride, with a focus on analyzing its pharmacological activity and mechanism of action. Combined with drug evaluation and pharmacokinetic data, it explores its clinical application prospects and future research directions, aiming to provide theoretical basis and technical reference for the drug development and clinical translation of this natural product.
Chemical structure and physicochemical properties
The chemical name of magnolol hydrochloride is (+) - Magnoline chloride, with a molecular formula of C20H24ClNO4 and a molecular weight of 342.4150. Its structure belongs to the aporphine alkaloids and has a typical isoquinoline skeleton. The molecule contains multiple hydroxyl and methoxy functional groups, endowing it with strong hydrophilicity and biological activity. Its structural features include a tetracyclic isoquinoline core with methoxy substituents and nitrogen atoms in the form of quaternary ammonium salts, making it cationic under physiological pH conditions.
In terms of physical and chemical properties, the LogP value of magnolol hydrochloride is -0.6749, indicating its strong hydrophilicity, which is beneficial for water solubility and in vivo distribution. Its topological polar surface area (TPSA) is 58.92 Å ², indicating moderate polarity that facilitates interaction with biological targets. The water solubility is 0.1529 (unit not specified, speculated to be in the g/L or mg/mL level), indicating that it has a certain solubility in water. The low blood-brain barrier permeability suggests limited penetration ability of the central nervous system, but this may also reduce the risk of central side effects. The negative result of hERG channel inhibition experiment indicates a low risk of cardiac toxicity. The Ames test result is 0.6, indicating a low risk of genotoxicity and a good safety foundation.
Plant sources and extraction methods
Magnolia alkaloids are widely present in plants of the Magnoliaceae family, especially in the roots, stem bark, leaves, and flowers of the Magnolia genus, which are rich in content. In addition, some poppy and buttercup plants also contain such alkaloids. Traditional Chinese medicinal herbs such as Magnolia officinalis and Magnolia flowers are important sources of this compound.
The extraction method mainly adopts polar solvent extraction combined with liquid chromatography separation technology. Common extraction techniques include:
- Solvent extraction Using methanol, ethanol, or water as extraction agents, crude extracts are obtained through reflux or ultrasound assisted extraction.
- Liquid-liquid distribution Use solvents of different polarities such as ethyl acetate and chloroform for distribution to remove lipophilic impurities.
- Column chromatography separation Using silica gel, C18 reverse phase column, etc. for separation and purification, combined with high-performance liquid chromatography (HPLC) to achieve the preparation of high-purity magnolol.
- Hydrochloric acid salinization To improve stability and water solubility, magnolol is usually converted into its hydrochloride form, which facilitates formulation development.
In recent years, green extraction techniques such as microwave-assisted extraction and supercritical fluid extraction have gradually been applied to the extraction of magnolol, improving extraction efficiency and environmental friendliness.
Pharmacological activity research
Anti inflammatory and immune regulatory effects
(+) - Magnoflorine regulates inflammatory response and immune function through multiple signaling pathways. Research has shown that it can promote Parkin/PINK1 mediated mitochondrial autophagy, clear damaged mitochondria, alleviate cellular oxidative stress, thereby inhibiting the activation of NLRP3 inflammasome and Caspase-1, reducing the secretion of pro-inflammatory factors such as IL-1 β and IL-18, and exhibiting significant anti-inflammatory effects. In addition, magnolol improves intestinal barrier function and further enhances immune homeostasis by regulating the composition of gut microbiota.
Neuroprotective effect
Oxidative stress and neuronal apoptosis are key pathological mechanisms in neurodegenerative diseases. (+) - Magnoflorine can reduce the release of inflammatory mediators and oxidative damage by inhibiting the JNK and TLR4/NF - κ B signaling pathways. Simultaneously activating the Sirt1/AMPK pathway promotes cellular energy metabolism and antioxidant defense, reduces neuronal apoptosis, improves cognitive function and neuroprotective effects. It has shown promising therapeutic potential in models such as Parkinson's disease and Alzheimer's disease.
Antitumor activity
Magnoliaalkaloid upregulates miR-410-3p, inhibits the HMGB1/NF - κ B signaling pathway, and blocks the proliferation, migration, and invasion of tumor cells. This mechanism involves regulating the cell cycle, inducing apoptosis, and inhibiting inflammatory responses in the tumor microenvironment, demonstrating broad-spectrum anti-tumor activity. Many in vitro and in vivo experiments have confirmed its inhibitory effect on breast cancer, lung cancer and gastric cancer cells.
Antifungal activity
(+) - Magnoflorine exhibits inhibitory effects on various pathogenic fungi, particularly strong bactericidal activity against Candida and Aspergillus species. Its mechanism of action may be related to the disruption of fungal cell membrane integrity and inhibition of fungal metabolism, providing new ideas for the development of natural antifungal drugs.
Cardiovascular protective effect
Magnolia alkaloids exert protective effects by regulating various cardiovascular related targets, including selectins (SELP), peroxisome proliferator activated receptor gamma (PPARG), angiotensin-converting enzyme (ACE), protein kinase B (AKT1), β 2-adrenergic receptor (ADRB2), potassium channel (KCNH2), nitric oxide synthase 3 (NOS3), intercellular adhesion molecule (ICAM1), and vascular cell adhesion molecule (VCAM1). It can alleviate atherosclerosis and myocardial injury by anti-oxidation, anti-inflammatory, improving vasodilation function and inhibiting platelet aggregation, and has potential value in the prevention and treatment of cardiovascular diseases.
Mechanism of action and molecular targets
The multi-target mechanism of action of magnolol is the basis for its diverse pharmacological activities. Mainly involving the following signaling pathways and molecular targets:
- Parkin/PINK1 mediated mitochondrial autophagy Promote selective clearance of damaged mitochondria, maintain mitochondrial function and cellular homeostasis.
- Inhibition of NLRP3/Caspase-1 pathway Block the assembly of inflammasomes and reduce the release of pro-inflammatory cytokines.
- Inhibition of TLR4/NF - κ B signaling pathway Inhibit inflammatory signal transduction and reduce the expression of inflammatory mediators.
- JNK pathway inhibition Reduce cellular stress response and apoptosis.
- Sirt1/AMPK pathway activation Enhance cellular metabolic regulation and antioxidant capacity.
- Upregulation of miR-410-3p and inhibition of HMGB1/NF - κ B pathway Regulating tumor cell proliferation and migration.
- Regulation of cardiovascular related targets By regulating multiple targets such as SELP, PPARG, ACE, etc., it exerts vascular protective effects.
These mechanisms work together to endow magnolol with a wide range of biological functions and therapeutic potential.
Evaluation of drug properties and pharmacokinetics
The pharmacological parameters of magnolol hydrochloride show that it has good potential for drug development. The molecular weight of 342.4150 is moderate and conforms to Lipinski's rule. A negative LogP value (-0.6749) indicates strong hydrophilicity, which facilitates oral absorption and in vivo distribution. The TPSA value of 58.92 Å ² is below the threshold of 140 Å ², indicating its good cell membrane penetration ability.
Moderate water solubility (0.1529) is beneficial for formulation design. The low blood-brain barrier permeability may limit the direct action of the central nervous system, but also reduce the risk of central toxicity. The negative inhibition of hERG channel and low toxicity results of Ames test indicate its good safety.
In terms of pharmacokinetics, existing studies have shown that magnolol is well absorbed orally, has a moderate plasma half-life, and is mainly metabolized and excreted through the liver. Its metabolic pathways include oxidation, methylation, and glucuronic acid binding. Due to its high polarity, renal excretion is also significant. Further systematic pharmacokinetic and toxicological evaluations are needed in the future to clarify its in vivo pharmacokinetic characteristics and safe dose range.
Clinical application prospects and prospects
Magnoliaine hydrochloride, as a natural product with multiple targets and mechanisms, has shown extensive potential in anti-inflammatory, neuroprotective, anti-tumor, and cardiovascular protection applications. Its good safety and pharmacological properties have laid the foundation for clinical translation.
The future clinical application prospects mainly include:
- Anti inflammatory and immunomodulatory drugs Suitable for adjuvant therapy of autoimmune diseases, chronic inflammation, and intestinal diseases.
- Neurodegenerative disease therapeutic agents Neuroprotective drugs for neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease.
- Antitumor adjuvant drugs Combining chemotherapy or targeted therapy to enhance anti-tumor efficacy and reduce side effects.
- Prevention and treatment of cardiovascular diseases It is used for the protection and treatment of atherosclerosis, hypertension and myocardial ischemia.
In addition, the antifungal activity of magnolol provides a new direction for the development of anti infective drugs. In the future, it is necessary to strengthen its preclinical efficacy evaluation, toxicology research, and pharmacokinetic optimization to promote its entry into the clinical trial stage.
Meanwhile, based on in-depth analysis of its molecular targets and mechanisms of action, its bioavailability and targeting can be improved through structural modification and optimization of drug delivery systems, expanding its clinical application scope.
Conclusion
As a natural aporphine alkaloid with multiple pharmacological activities, magnolol hydrochloride has shown broad research and application prospects in the fields of anti-inflammatory, neuroprotective, anti-tumor, and cardiovascular protection due to its unique chemical structure and multi-target mechanism of action. Its good drug efficacy and safety provide strong support for the development of new drugs.
Future research should focus on in-depth analysis of its molecular mechanism, optimization of extraction and purification processes, improvement of pharmacokinetic and toxicological evaluations, promotion of preclinical and clinical studies, full exploration of the medicinal value of magnolol, and promotion of it as an important candidate for natural product drug development. Through interdisciplinary collaboration, magnolol is expected to provide new drug options for the treatment of various diseases, promoting the development and innovation of natural product pharmacology.
